4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-17-001170
Chief Scientific Officer sold 52,814 shares at $6.33 ($334,313)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2017-04-19 | Sale | −52,814 | $6.33 | $334,313 | 89,636 | D: show line 1 in the form |
| Open-market sales · 52,814 sh · avg $6.33 · $334,313 | |||||||
Loading xslF345X03/zk1719828.xml…